MeinelFGDe CeccoCNSchoepfUJKatzbergR. Contrast-induced acute kidney injury: Definition, epidemiology, and outcome. Biomed Res Int. 2014;2014:859328.
2.
Ad-hoc working group of ERBP; Fliser D, Laville M, Covic A, et al. A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: Definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant. 2012;27:4263-4272.
3.
NashKHafeezAHouS. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39:930-936.
4.
GurmHSSethMKooimanJShareD. A novel tool for reliable and accurate prediction of renal complications in patients undergoing percutaneous coronary intervention. J Am Coll Cardiol. 2013;61:2242-2248.
5.
Mehran R, Nikolsky E. Contrast-induced nephropathy: Definition, epidemiology, and patients at risk. Kidney Int. 2006;69(Suppl 100):S11-S15.
6.
LasserECLyonSGBerryCC. Reports on contrast media reactions: Analysis of data from reports to the U.S. Food and drug administration. Radiology. 1997;203:605-610.
7.
BernsAS. Nephrotoxicity of contrast media. Kidney Int. 1989;36:730-740.
8.
NikolskyEMehranRTurcotD, et al.Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention. Am J Cardiol. 2004;94:300-305.
9.
KaraaslanHUyarNGöçerEGCindoğluÇErenMASabuncuT. An analysis of the prevalence and risk factors of contrast-associated acute kidney injury in patients with diabetic foot ulcer. Angiology. 2023;74:624‐630.
10.
LiYRenK. The mechanism of contrast-induced acute kidney injury and its association with diabetes mellitus. Contrast Media Mol Imaging. 2020;2020:3295176.
11.
PapachristouSPafiliKPapanasN. Skin AGEs and diabetic neuropathy. BMC Endocr Disord. 2021;21:28.
12.
KatsikiNAthyrosVGKaragiannisAMikhailidisDP. Contrast-induced nephropathy: an “all or none” phenomenon?Angiology. 2015;66:508-513.
